Table 3.
A | Acute oral toxicity | |||||
Sex | Control | DC 300 mg/kg | DC 2000 mg/kg | P value | ||
Heart | F (n = 3) | 0.37 ± 0.02 | 0.35 ± 0.01 | 0.35 ± 0.03 | 0.422 | |
Liver | F (n = 3) | 2.58 ± 0.14 | 2.60 ± 0.12 | 2.50 ± 0.13 | 0.601 | |
Kidney | F (n = 3) | 0.70 ± 0.02 | 0.67 ± 0.03 | 0.68 ± 0.02 | 0.484 | |
Spleen | F (n = 3) | 0.18 ± 0.02 | 0.18 ± 0.02 | 0.18 ± 0.01 | 0.952 | |
Lung | F (n = 3) | 0.49 ± 0.01 | 0.48 ± 0.02 | 0.48 ± 0.02 | 0.874 | |
B | Sub-acute oral toxicity | |||||
Sex | Control | DC 500 mg/kg | DC 1000 mg/kg | DC 1500 mg/kg | P value | |
Heart | M (n = 5) | 0.36 ± 0.02 | 0.35 ± 0.02 | 0.34 ± 0.02 | 0.34 ± 0.03 | 0.757 |
F (n = 5) | 0.37 ± 0.02 | 0.37 ± 0.03 | 0.37 ± 0.02 | 0.38 ± 0.02 | 0.938 | |
Liver | M (n = 5) | 2.92 ± 0.15 | 2.81 ± 0.10 | 2.87 ± 0.17 | 2.92 ± 0.14 | 0.593 |
F (n = 5) | 2.45 ± 0.09 | 2.38 ± 0.07 | 2.35 ± 0.05 | 2.43 ± 0.07 | 0.114 | |
Kidney | M (n = 5) | 0.75 ± 0.02 | 0.75 ± 0.03 | 0.76 ± 0.02 | 0.76 ± 0.03 | 0.930 |
F (n = 5) | 0.69 ± 0.03 | 0.70 ± 0.02 | 0.70 ± 0.05 | 0.72 ± 0.04 | 0.639 | |
Spleen | M (n = 5) | 0.19 ± 0.02 | 0.19 ± 0.02 | 0.18 ± 0.03 | 0.19 ± 0.02 | 0.937 |
F (n = 5) | 0.18 ± 0.02 | 0.18 ± 0.02 | 0.18 ± 0.02 | 0.19 ± 0.02 | 0.835 | |
Lung | M (n = 5) | 0.40 ± 0.02 | 0.40 ± 0.02 | 0.39 ± 0.02 | 0.42 ± 0.01 | 0.241 |
F (n = 5) | 0.49 ± 0.02 | 0.48 ± 0.02 | 0.49 ± 0.01 | 0.50 ± 0.02 | 0.536 |
Values expressed as a mean ± standard deviation. Sex (male, M and female, F)
*p-value less than 0.05, (p < 0.05) significant value